Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oncternal Therapeutics, Inc.

0.5266
+0.0000
Volume:- -
Turnover:- -
Market Cap:1.56M
PE:-0.05
High:0.5266
Open:0.5266
Low:0.5266
Close:0.5266
Loading ...
Mar 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2021

Major Issues Report

8-K - Current report
Dec 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 18, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 11, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 10, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 19, 2020

Major Issues Report

8-K - Current report
Nov 18, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 17, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2020

Major Issues Report

8-K - Current report
Aug 31, 2020

Major Issues Report

8-K - Current report
Aug 28, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses